XML 59 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1

Segment and Geographic Information (Tables)

12 Months Ended

Dec. 28, 2018

Segment Reporting [Abstract]

Schedule of segment sales by product line

The following table presents sales by product line for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment sales by product line:
Medical
Cardio & Vascular	$	585,464			$	530,831			$	484,891
Cardiac & Neuromodulation	443,347				428,275				439,375
Advanced Surgical, Orthopedics & Portable Medical	133,225				120,006				109,557
Total Medical	1,162,036				1,079,112				1,033,823
Non-Medical	52,976				56,968				41,679
Total sales	$	1,215,012			$	1,136,080			$	1,075,502

Schedule of Revenue by Major Customers by Reporting Segments

A significant portion of the Company’s sales for fiscal years 2018, 2017 and 2016 and accounts receivable at December 28, 2018 and December 29, 2017 were to three customers as follows:

	Sales						Accounts Receivable
	2018		2017		2016		December 28, 2018		December 29, 2017
Customer A	21%		22%		24%		11%		11%
Customer B	19%		20%		21%		18%		21%
Customer C	12%		11%		12%		20%		20%
	52%		53%		57%		49%		52%

Schedule of segment depreciation and amortization

The following table presents depreciation and amortization expense for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment depreciation and amortization:
Medical	$	71,922			$	72,314			$	65,528
Non-Medical	1,364				2,675				2,346
Total depreciation and amortization included in segment    income from operations	73,286				74,989				67,874
Unallocated depreciation and amortization	8,252				6,194				4,994
Total depreciation and amortization	$	81,538			$	81,183			$	72,868

Schedule of segment income (loss) from operations

The following table presents income from operations for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment income from operations:
Medical	$	224,893			$	197,212			$	170,101
Non-Medical	14,697				11,335				1,513
Total segment income from operations	239,590				208,547				171,614
Unallocated operating expenses	(84,035		)		(82,898		)		(78,691		)
Operating income	155,555				125,649				92,923
Unallocated expenses, net	(94,439		)		(76,390		)		(64,758		)
Income before benefit for income taxes	$	61,116			$	49,259			$	28,165

Schedule of long-lived tangible assets and identifable assets by geographic area

The following table presents PP&E by geographic area as of December 28, 2018 and December 29, 2017. In these tables, PP&E is aggregated based on the physical location of the tangible long-lived assets (in thousands).

	December 28, 2018				December 29, 2017
Long-lived tangible assets by geographic area:
United States	$	151,851			$	157,808
Mexico	34,606				28,985
Ireland	32,190				33,992
Rest of world	12,622				14,395
Total	$	231,269			$	235,180

The following table presents total assets for the Company’s reportable segments as of December 28, 2018 and December 29, 2017 (in thousands).

	December 28, 2018				December 29, 2017
Identifiable assets:
Medical(1)	$	2,186,565			$	2,687,227
Non-Medical	53,812				54,071
Total reportable segments	2,240,377				2,741,298
Unallocated assets	86,304				107,047
Total assets	$	2,326,681			$	2,848,345

Schedule of expenditures for tangible long-lived assets, excluding acquisitions

The following table presents capital expenditures for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Expenditures for tangible long-lived assets:
Medical	$	34,615			$	20,896			$	27,014
Non-Medical	573				661				1,451
Total reportable segments	35,188				21,557				28,465
Unallocated long-lived tangible assets	6,110				8,783				8,251
Total expenditures	$	41,298			$	30,340			$	36,716

Schedule of sales by geographic area

The following table presents sales by significant country for fiscal years 2018, 2017 and 2016. In these tables, sales are allocated based on where the products are shipped (in thousands).

	2018				2017				2016
Sales by geographic area:
United States	$	687,259			$	662,133			$	625,670
Non-Domestic locations:
Puerto Rico	146,500				140,184				162,343
Costa Rica	62,044				55,364				53,501
Rest of world	319,209				278,399				233,988
Total sales	$	1,215,012			$	1,136,080			$	1,075,502

Segment Reporting Disclosure [Text Block]

The following table presents sales by customer for fiscal year 2018.

Customer		Medical			Non-Medical
Customer A		22	%		—	%
Customer B		19	%		—	%
Customer C		12	%		—	%
Customer D		—	%		28	%
All other customers		47	%		72	%

(17.) SEGMENT AND GEOGRAPHIC INFORMATION

The Company organizes its business into two reportable segments: (1) Medical and (2) Non-Medical. This segment structure reflects the financial information and reports used by the Company’s management, specifically its Chief Operating Decision Maker (“CODM”), to make decisions regarding the Company’s business, including resource allocations and performance assessments. This segment structure reflects the Company’s current operating focus in compliance with ASC 280, Segment Reporting.

The Company defines segment income from operations as sales less cost of sales including amortization and expenses attributable to segment-specific selling, general, administrative, research, development, engineering and other operating activities. The remaining unallocated operating and other expenses are primarily administrative corporate headquarter expenses and capital costs that are not allocated to reportable segments. Transactions between the two segments are not significant.

(17.)     SEGMENT AND GEOGRAPHIC INFORMATION (Continued)

The following table presents sales by product line for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment sales by product line:
Medical
Cardio & Vascular	$	585,464			$	530,831			$	484,891
Cardiac & Neuromodulation	443,347				428,275				439,375
Advanced Surgical, Orthopedics & Portable Medical	133,225				120,006				109,557
Total Medical	1,162,036				1,079,112				1,033,823
Non-Medical	52,976				56,968				41,679
Total sales	$	1,215,012			$	1,136,080			$	1,075,502

A significant portion of the Company’s sales for fiscal years 2018, 2017 and 2016 and accounts receivable at December 28, 2018 and December 29, 2017 were to three customers as follows:

	Sales						Accounts Receivable
	2018		2017		2016		December 28, 2018		December 29, 2017
Customer A	21%		22%		24%		11%		11%
Customer B	19%		20%		21%		18%		21%
Customer C	12%		11%		12%		20%		20%
	52%		53%		57%		49%		52%

The following table presents income from operations for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment income from operations:
Medical	$	224,893			$	197,212			$	170,101
Non-Medical	14,697				11,335				1,513
Total segment income from operations	239,590				208,547				171,614
Unallocated operating expenses	(84,035		)		(82,898		)		(78,691		)
Operating income	155,555				125,649				92,923
Unallocated expenses, net	(94,439		)		(76,390		)		(64,758		)
Income before benefit for income taxes	$	61,116			$	49,259			$	28,165

The following table presents depreciation and amortization expense for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Segment depreciation and amortization:
Medical	$	71,922			$	72,314			$	65,528
Non-Medical	1,364				2,675				2,346
Total depreciation and amortization included in segment    income from operations	73,286				74,989				67,874
Unallocated depreciation and amortization	8,252				6,194				4,994
Total depreciation and amortization	$	81,538			$	81,183			$	72,868

(17.)     SEGMENT AND GEOGRAPHIC INFORMATION (Continued)

The following table presents total assets for the Company’s reportable segments as of December 28, 2018 and December 29, 2017 (in thousands).

	December 28, 2018				December 29, 2017
Identifiable assets:
Medical(1)	$	2,186,565			$	2,687,227
Non-Medical	53,812				54,071
Total reportable segments	2,240,377				2,741,298
Unallocated assets	86,304				107,047
Total assets	$	2,326,681			$	2,848,345

^__________ 

⁽¹⁾  Medical segment identifiable assets at December 29, 2017 includes $451.4 million of assets held sale.

The following table presents capital expenditures for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).

	2018				2017				2016
Expenditures for tangible long-lived assets:
Medical	$	34,615			$	20,896			$	27,014
Non-Medical	573				661				1,451
Total reportable segments	35,188				21,557				28,465
Unallocated long-lived tangible assets	6,110				8,783				8,251
Total expenditures	$	41,298			$	30,340			$	36,716

Geographic Area Information

The following table presents sales by significant country for fiscal years 2018, 2017 and 2016. In these tables, sales are allocated based on where the products are shipped (in thousands).

	2018				2017				2016
Sales by geographic area:
United States	$	687,259			$	662,133			$	625,670
Non-Domestic locations:
Puerto Rico	146,500				140,184				162,343
Costa Rica	62,044				55,364				53,501
Rest of world	319,209				278,399				233,988
Total sales	$	1,215,012			$	1,136,080			$	1,075,502

The following table presents PP&E by geographic area as of December 28, 2018 and December 29, 2017. In these tables, PP&E is aggregated based on the physical location of the tangible long-lived assets (in thousands).

	December 28, 2018				December 29, 2017
Long-lived tangible assets by geographic area:
United States	$	151,851			$	157,808
Mexico	34,606				28,985
Ireland	32,190				33,992
Rest of world	12,622				14,395
Total	$	231,269			$	235,180

(17.)     SEGMENT AND GEOGRAPHIC INFORMATION (Continued)

Disaggregation of Revenue by Segment

In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations. Additionally, the tables below disaggregate the Company’s revenues based upon significant customers, which are defined as any customer who individually represents 10% or more of a segment’s total revenues, and ship to country, which is defined as any country where 10% or more of a segment’s total revenues are shipped to. The Company believes that these categories best depict how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors.

The following table presents sales by customer for fiscal year 2018.

Customer		Medical			Non-Medical
Customer A		22	%		—	%
Customer B		19	%		—	%
Customer C		12	%		—	%
Customer D		—	%		28	%
All other customers		47	%		72	%

The following table presents revenues by ship to country for fiscal year 2018.

Ship to Location		Medical		Non-Medical
United States		56%		66%
Puerto Rico		13%		—%
Canada		—%		11%
All other Countries		31%		23%

X

- Definition

-- None. No documentation exists for this element. --

+ References

No definition available.

+ Details

Name:	gb_ReconciliationOfDepreciationAndAmortizationByReportableSegmentToConsolidatedTableTextBlock
Namespace Prefix:	gb_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

-- None. No documentation exists for this element. --

+ References

No definition available.

+ Details

Name:	gb_ScheduleOfExpendituresForTangibleLonglivedAssetsBySegmentTableTextBlock
Namespace Prefix:	gb_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599

+ Details

Name:	us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration